ROCKVILLE, Md., May 4, 2015 /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”) today announced that an independent team of researchers from South Korea have reported that Thymosin B4 (TB4) plays an important role in accelerating the repair…


Source: PrNewwire

Related Posts Plugin for WordPress, Blogger...